Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rakovina Therapeutics Inc. has successfully closed an oversubscribed $3 million private placement, which will accelerate the development of its cutting-edge cancer therapies. The company also announced a partnership with Fairfax Partners Inc. to enhance its market presence and expand its investor base through a comprehensive investor relations program.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.